MesoWatch
The toughest tort. The smartest approach.
Mesothelioma is the most expensive keyword in legal advertising. CPCs exceed $200. Competition is ruthless. We built something different: editorial that ranks in Google News and Discover, CTV that reaches patients through healthcare data, and intelligence that tracks every meso ad nationwide.
The most competitive market in legal advertising
Mesothelioma cases are worth millions. That makes the marketing space brutal. National firms spend eight figures annually on TV and digital. CPCs for core keywords routinely exceed $200. Some hit $900.
Buying your way in is a losing game unless you have the deepest pockets. The alternative: earn attention through content that actually helps people facing a devastating diagnosis.
Google News and Discover optimized
We didn't build a marketing site. We built a medical news resource optimized for Google's editorial surfaces. The kind of content that earns placement in News and Discover feeds, not just organic search results.
Medical-grade journalism
Every article written by medical writers with oncology expertise. Peer-reviewed sources. Clear citations. The editorial standards Google News requires for health content.
News and Discover optimization
Structured for Google's editorial algorithms. Fresh content cadence, proper schema markup, E-E-A-T signals throughout. Reaching patients in their feeds, not just search results.
Turnkey campaign infrastructure
Everything built to deploy. CTV creative guidelines, audience segments ready, tracking in place. When you want to run meso, we're ready to go.
Behavioral healthcare audiences for CTV prospecting
Search-based targeting in mesothelioma is a money pit. Everyone bids on the same keywords. We took a different approach: reach patients based on actual healthcare behavior, not search queries.
Using deterministic healthcare data, we build audiences of people who have actually undergone mesothelioma procedures. Surgery, radiation therapy, diagnosis codes. Not people who searched for symptoms. People who have the condition.
Why this matters
Every competitor targets the same search queries. We reach patients on CTV before they ever type a keyword. When they do search, they've already seen us on the biggest screen in the house.
A complete content infrastructure
- Google News and Discover optimization
- Medical writer network with oncology expertise
- Behavioral healthcare audience targeting (LASSO)
- Daily nationwide meso ad tracking
- Turnkey CTV campaign infrastructure
The editorial difference
Most legal content in this space is thin, keyword-stuffed, and written by generalists. MesoWatch content is written by medical professionals, fact-checked against primary sources, and updated quarterly. Google News notices. Readers notice more.
Every meso ad. Every market. Daily.
We track every mesothelioma advertisement running nationwide. Television, CTV, digital. Every market, every day. This isn't competitive monitoring. It's market intelligence infrastructure.
Nationwide coverage
Every DMA tracked for mesothelioma advertising activity
Daily updates
Fresh data on spend levels, creative rotation, and channel mix
Competitive positioning
Know where competitors are heavy, where they're absent
Why this matters
When you know where every competitor is spending, you can find the gaps. Markets they've abandoned. Dayparts they're ignoring. Creative fatigue they haven't noticed. Intelligence drives better media buying.
Three channels. One infrastructure.
MesoWatch isn't a campaign. It's turnkey infrastructure for mesothelioma marketing. Editorial that earns visibility, CTV that reaches patients, intelligence that finds the gaps.
Google News and Discover optimized. Ranking where competitors can't buy their way in.
Healthcare data targeting. Reaching actual patients, not keyword searchers.
Every meso ad tracked daily. Finding gaps before competitors do.
Your market has a content gap too
Every competitive legal vertical has the same problem: everyone buys the same keywords with the same thin content. We build the editorial infrastructure that earns attention instead.
Talk about your market